Adam Bluestein
Selected Work
“This company’s drug could effectively end the HIV epidemic—but patients remember how it slow-walked a past treatment.” Print feature on the development of Gilead Sciences’ groundbreaking PrEP shot, lenacapavir. Fast Company, June 2025
“How the federal government is tracking changes in the supply of street drugs.” Scientsts at the National Institute of Standards and Technology’s are using advance analysis to prevent overdoses and reduce dangerous side effects of illicit drug ingredients. MIT Technology Review, April 2025
“Phineas and Ferb are making a mischievous return, targeting multiple generations of fans.” I spoke with the creators of Disney’s hit animated series and company execs about the show’s long-awaited comeback. Fast Company, April 2025
“How to Focus Like Your Life Depends On It.” Formula 1 driver Oscar Piastri and others share strategies for paying attention on course and in life. New York Times, November 2024
“This startup is building the country’s most powerful quantum computer on Chicago’s South Side.” How PsiQuantum emerged as a leader in the race to build a utility-scale quantum computer. Fast Company, July 2024
“Ozempic for Everyone? Inside Novo Nordisk’s Big Plans for Its Weight-Loss Drugs.” How the Danish diabetes specialist shifted gears and targeted the U.S. market with its GLP-1 blockbusters. Fast Company, December 2023
“Moderna became a hero with its COVID-19 vaccine—now comes the hard part.”
Profile of pandemic darling and mRNA pioneer and its efforts to deliver new treatments. Fast Company, June 2023
“The Lock-Picker, the Lockmaker, and the Odyssey to Expose a Major Security Flaw.”
Ethical hackers take on the security industry. Bloomberg Businessweek, December 2021
“How Mormons Built the Next Silicon Valley While No One Was Looking.” LDS religious values infuse Utah’s blazing-hot tech scene. As businesses seek to lure outsiders, does that need to change? Marker, January 2020
“Flower Power.” How Mikey Steinmetz, CEO and cofounder of craft-grown cannabis distributor Flow Kana, is helping multi-generation Emerald Triangle growers weather the storms of legalization. Men’s Journal, January/February 2020
“After a Comeback, 23andMe Faces Its Next Test.” Profile of Anne Wojcicki, CEO of the pioneering consumer genomics company. Fast Company, September 2017